References
- Park SD. Herb medicine-inducedadverse effects in dermatological field. J Korean Med Assoc 2005 April 30 [Epub]. http://dx. doi.org/10.5124/jkma.2005.48.4.325.
- Kim KJ, Lee SY, Choi KC, Chung BS. Differences in Antigen-presenting cells in dermatitis due to skin contact and ingestion of lacquer tree. Korean J Dermatol 2001;39:1238-1245.
- Won TH, Seo PS, Park SD, Kim DL, Park JH. Clinical features in 147 patients with systemic contact dermatitisdue to the ingestion of chicken boiled with japanese lacquer tree. Korean J Dermatol 2008;46:761-768.
- Cohen LM, Cohen JL. Erythema multiforme associated with contact dermatitis to poison ivy: three cases and a review of the literature. Cutis 1998;62:139-142.
- Trent J, Halem M, French LE, Kerdel F. Toxic epidermal necrolysis and intravenous immunoglobulin: a review. Semin Cutan Med Surg 2006;25:91-93. https://doi.org/10.1016/j.sder.2006.04.004
- French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int 2006;55:9-16. https://doi.org/10.2332/allergolint.55.9
- Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-1285. https://doi.org/10.1056/NEJM199411103311906
- Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-1607. https://doi.org/10.1056/NEJM199512143332404
- Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Welkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-153. https://doi.org/10.1046/j.1523-1747.2000.00061.x
- Harr T, French LE. Severe cutaneousadverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome. Med Clin North Am 2010;94: 727-742. https://doi.org/10.1016/j.mcna.2010.04.004
- Fournier S, Bastuji-Garin S, Mentec H, Revuz J, Roujeau JC. Toxic epidermal necrolysis associated with mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis 1995; 14:558-559. https://doi.org/10.1007/BF02113442
- Avakian R, Flowers FP, Araujo OE, Ramos-Caro FA. Toxic epidermal necrolysis: a review. J Am Acad Dermatol 1991;25(1 Pt 1):69-79. https://doi.org/10.1016/0190-9622(91)70176-3
- Lee JH, Lee YM. A case of Stevens-Johnson syndrome caused by ciprofloxacin. Korean J Med 2008;75:909-912.
- Ma JE, Kim HS, Park DJ, et al. A case of Stevens-Johnson syndrome induced by gabapentin. Korean J Asthma Allergy Clin Immunol 2007;27:283-286.
- Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008;14:1343-1350. https://doi.org/10.1038/nm.1884
- Mangla K, Rastogi S, Goyal P, Solanki RB, Rawal RC. Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: an open uncontrolled study. Indian J Dermatol Venereol Leprol 2005;71:398-400. https://doi.org/10.4103/0378-6323.18943
- Tristani-Firouzi P, Petersen MJ, Saffle JR, Morris SE, Zone JJ. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 2002;47: 548-552. https://doi.org/10.1067/mjd.2002.127249
- Zipitis CS, Thalange N. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. Eur J Pediatr 2007;166:585-588. https://doi.org/10.1007/s00431-006-0287-9
- Wolf R, Davidovici B. Severe cutaneous adverse drug reactions: who should treat, where and how? Facts and controversies. Clin Dermatol 2010;28:344-348. https://doi.org/10.1016/j.clindermatol.2009.06.020
- De Prost N, Ingen-Housz-Oro S, Duong T, et al. Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures. Medicine (Baltimore) 2010;89:28-36. https://doi.org/10.1097/MD.0b013e3181ca4290